Methods for enhancing the efficacy of cytotoxic agents through the use of HSP90 inhibitors

Details for Australian Patent Application No. 2002228772 (hide)

Owner Sloan Kettering Institute for Cancer Research

Inventors Rosen, Neal; Munster, Pamela

Agent Freehills

Pub. Number AU-B-2002228772

PCT Pub. Number WO02/36171

Priority 60/245,375 02.11.00 US

Filing date 1 November 2001

Wipo publication date 15 May 2002

Acceptance publication date 8 December 2005

International Classifications

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

G01N 033/535 Investigating or analysing materials by specific methods not covered by groups - with enzyme label

A61K 038/43 Medicinal preparations containing peptides - Enzymes

Event Publications

8 December 2005 Application Accepted

  Published as AU-B-2002228772

6 April 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228773

2002228771-Small molecule compositions for binding to HSP90